UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Realta Investment Advisors

Realta Investment Advisors reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,209 shares of the healthcare conglomerate’s stock after selling 256 shares during the period. Realta Investment Advisors’ holdings in UnitedHealth Group were worth $620,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Genesee Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 18 shares during the last quarter. Jmac Enterprises LLC grew its stake in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. Powers Advisory Group LLC lifted its holdings in UnitedHealth Group by 4.8% during the 3rd quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock worth $244,000 after buying an additional 19 shares in the last quarter. Wallace Capital Management Inc. lifted its stake in shares of UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after acquiring an additional 19 shares during the period. Finally, Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $529.71 on Friday. The firm has a market capitalization of $487.48 billion, a PE ratio of 34.17, a PEG ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business’s 50-day simple moving average is $530.85 and its 200 day simple moving average is $564.52. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.83 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.